Connect
An entire industry started with an idea. Founded in 2008, Caris Life Sciences® is on a mission to help patients, clinicians, researchers, and payors navigate, advance and reinvent cancer care. Our unique combination of expertise, proprietary technologies, clinical testing capabilities, and extensive library of clinical data enables us to advance precision medicine.
We exist to save the lives of cancer patients.
Caris Life Sciences was founded with a very simple but powerful purpose – to help improve the lives of as many people as possible. With transformative technologies, we are revolutionizing precision medicine to provide physicians and patients with the highest quality information about their health. Through tireless efforts, breakthrough molecular science and a passionate commitment to quality, we remain steadfastly focused on the most important part of our work – the patient.”
David D. Halbert
Chairman & CEO
Caris Life Sciences
News & Media
Loading...
Webinars
Title: Caris Clinical Trial Spotlight: IDEAYA Biosciences: PKC inhibitor darovasertib (IDE196) effectively targets GNAQ/11 mutations in cancer
Description: Join Caris Pharmatech and Dr. Matthew Mauer, Vice President, Head of Medical Affairs and Clinical Oncology – IDEAYA Biosciences, for discussion on updated data results from IDE196.
Date: Wednesday, June 30, 2021
Time: 3:00 – 3:30pm
Webinar Archive
We’re regularly adding to our archive of past webinars. View the full history of Caris Life Science webinars by clicking the button below.
Podcasts
The Caris Molecular Minute is a podcast series led by Dr. Chadi Nabhan, Chairman of the Caris Precision Oncology Alliance™ who interviews many of today’s leading oncology experts and covers a variety of hot topics in precision oncology and advancing cancer care.
Caris Molecular Minute Podcast Library
Review and listen to each episode of the Caris Molecular Minute podcast series by clicking the button below.
Support
HOURS OF OPERATION
Monday – Friday,7:00 AM – 7:00 PM (CT)